SAB also has therapeutic effects on a variety of cancers, such as lung, breast, oral squamous cell carcinoma, head and neck cancer, hepatocellular carcinoma, and glioma cancer cell lines. The gene discussed is SH3BP5; the disease is hepatocellular carcinoma.